Advances of Ribonucleotide Reductase Inhibitors on Cancer
Ribonucleotide reductase (RR) regulates dNTP production, catalyzing the reduction of ribonucleotide into deoxyribonucleotide diphosphate, which is essential in DNA synthesis and cell proliferation. RR overexpression is related with the tumorigenesis and tumor progression. At present, RR inhibitors h...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | zho |
Published: |
Magazine House of Cancer Research on Prevention and Treatment
2019-08-01
|
Series: | Zhongliu Fangzhi Yanjiu |
Subjects: | |
Online Access: | http://html.rhhz.net/ZLFZYJ/html/8578.2019.19.0100.htm |
id |
doaj-3431f595ada94e5cabc611d99cf475b6 |
---|---|
record_format |
Article |
spelling |
doaj-3431f595ada94e5cabc611d99cf475b62020-11-25T03:05:17ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85781000-85782019-08-0146874174510.3971/j.issn.1000-8578.2019.19.01008578.2019.19.0100Advances of Ribonucleotide Reductase Inhibitors on CancerWANG An'ge0WU Zhe1WANG Li2QIU Yunqing3State Key Laboratory for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital, Zhejiang University, Hangzhou 310000, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital, Zhejiang University, Hangzhou 310000, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital, Zhejiang University, Hangzhou 310000, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang Provincial Key Laboratory for Drug Clinical Research and Evaluation, The First Affiliated Hospital, Zhejiang University, Hangzhou 310000, ChinaRibonucleotide reductase (RR) regulates dNTP production, catalyzing the reduction of ribonucleotide into deoxyribonucleotide diphosphate, which is essential in DNA synthesis and cell proliferation. RR overexpression is related with the tumorigenesis and tumor progression. At present, RR inhibitors have been used on clinical cancer treatment, and new anticancer drugs have been developed targeting RR and its subunits, which may provide new options for cancer therapy. This review discusses the structure and function of RR, the role of RR on cancer therapy, and future application of RR inhibitors.http://html.rhhz.net/ZLFZYJ/html/8578.2019.19.0100.htmribonucleotide reductaseenzyme inhibitorstumor |
collection |
DOAJ |
language |
zho |
format |
Article |
sources |
DOAJ |
author |
WANG An'ge WU Zhe WANG Li QIU Yunqing |
spellingShingle |
WANG An'ge WU Zhe WANG Li QIU Yunqing Advances of Ribonucleotide Reductase Inhibitors on Cancer Zhongliu Fangzhi Yanjiu ribonucleotide reductase enzyme inhibitors tumor |
author_facet |
WANG An'ge WU Zhe WANG Li QIU Yunqing |
author_sort |
WANG An'ge |
title |
Advances of Ribonucleotide Reductase Inhibitors on Cancer |
title_short |
Advances of Ribonucleotide Reductase Inhibitors on Cancer |
title_full |
Advances of Ribonucleotide Reductase Inhibitors on Cancer |
title_fullStr |
Advances of Ribonucleotide Reductase Inhibitors on Cancer |
title_full_unstemmed |
Advances of Ribonucleotide Reductase Inhibitors on Cancer |
title_sort |
advances of ribonucleotide reductase inhibitors on cancer |
publisher |
Magazine House of Cancer Research on Prevention and Treatment |
series |
Zhongliu Fangzhi Yanjiu |
issn |
1000-8578 1000-8578 |
publishDate |
2019-08-01 |
description |
Ribonucleotide reductase (RR) regulates dNTP production, catalyzing the reduction of ribonucleotide into deoxyribonucleotide diphosphate, which is essential in DNA synthesis and cell proliferation. RR overexpression is related with the tumorigenesis and tumor progression. At present, RR inhibitors have been used on clinical cancer treatment, and new anticancer drugs have been developed targeting RR and its subunits, which may provide new options for cancer therapy. This review discusses the structure and function of RR, the role of RR on cancer therapy, and future application of RR inhibitors. |
topic |
ribonucleotide reductase enzyme inhibitors tumor |
url |
http://html.rhhz.net/ZLFZYJ/html/8578.2019.19.0100.htm |
work_keys_str_mv |
AT wangange advancesofribonucleotidereductaseinhibitorsoncancer AT wuzhe advancesofribonucleotidereductaseinhibitorsoncancer AT wangli advancesofribonucleotidereductaseinhibitorsoncancer AT qiuyunqing advancesofribonucleotidereductaseinhibitorsoncancer |
_version_ |
1724679467999166464 |